Sep 30, 2015, 11:41 AM by Michael Croft

The Atlantic | Evolution has sculpted the human genome to cope with Earth's toughest climates, inadvertently pointing geneticists towards medically important genes.

Sep 30, 2015, 11:18 AM by Michael Croft

CAMBRIDGE, UK - Sep 30, 2015 - Tom Weaver, CEO of Cambridge-based Congenica is delighted that its technology is reaching patients and says; “One of the aims of Genomics England is to enable NHS patients to gain early benefit from advances in genomics and through participation in the 100,000 Genomes Project we have been able to accelerate development of our Sapientia™ diagnostic platform

Sep 29, 2015, 21:05 PM by Michael Croft

Bio-IT World | Stephen Kingsmore and his colleagues at the Center for Pediatric Genomic Medicine at Children’s Mercy in Kansas City, announced 26-hour diagnostic whole genome sequencing in a paper published today in Genomic Medicine, an improvement over the 50-hour whole genome sequencing the group published in 2012. The paper is published just one day after Kingsmore took his new post as President and CEO of the Rady Pediatric Genomics and Systems Medicine Institute at Rady Children’s Hospital in San Diego.

Sep 29, 2015, 10:42 AM by Michael Croft

The Street | Anger over a price hike at Turing Pharmaceuticals and a Congressional letter to Valeant have dealt a blow to biotech stocks that many observers already fretted were sharply overvalued.

Sep 29, 2015, 08:37 AM by Michael Croft

CAMBRIDGE UK, UK - Sep 29, 2015 - Life Sciences Minister George Freeman MP today announced at the GREAT Healthcare Week at the Milan Expo, that Congenica, a world leading developer of genome-based discovery and diagnostic technologies, has been awarded £300,000 by Innovate UK as part of its ‘Finding value in complex data’ competition

Sep 28, 2015, 09:30 AM by Michael Croft

Bio-IT World | Emerald Cloud Labs' robotics facility for programmable scientific experiments is up and running in South San Francisco, as Bio-IT World editor Allison Proffitt reports from inside the lab.

Sep 25, 2015, 15:15 PM by Michael Croft

Diagnostics World | This Thursday, the FDA sent a letter to Pathway Genomics warning the company that a newly introduced test, a liquid biopsy to find early-stage cancer in apparently healthy people, has not been clinically validated and could be harmful to public health. The letter not only calls attention to the shaky evidence for this test's accuracy, but also asserts the FDA's authority over a whole category of tests in a regulatory gray area.

Sep 25, 2015, 11:06 AM by Michael Croft

Omics! Omics! Blog | Nabsys and its all-electronic single molecule physical mapping approach closed its doors a little over a week ago.

Sep 24, 2015, 16:37 PM by Michael Croft

Computerworld | Tamr's enterprise metadata catalog can help companies create an inventory of their data sources, including metadata about who owns the source.

Sep 24, 2015, 09:31 AM by Michael Croft

HARDERWIJK, THE NETHERLANDS - Sep 24, 2015 - Today, GENALICE announced the global launch date of Population Calling, a new analysis module and part of their GENALICE MAP Next-Generation Sequencing (NGS) Data Analysis Suite

Sep 24, 2015, 09:00 AM by Michael Croft

Fortune | IBM plans to open a new San Francisco office next year dedicated to growing its Watson supercomputing business. The location will give IBM direct access to the Bay Area startups.

Sep 23, 2015, 14:50 PM by Michael Croft

San Diego Union-Tribune | Craig Venter's latest company, Human Longevity, Inc., has announced a partnership with health insurer Discovery Ltd. of the U.K. and South Africa to offer patients whole exome sequencing for $250, a service Venter hopes to extend to the U.S.

Sep 21, 2015, 13:00 PM by Michael Croft

Bio-IT World  | The Garvan Institute of Medical Research in Sydney was one of the first three groups to sign up for Illumina’s HiSeq X Ten sequencing platform in 2014, a system that produced up to 5TB of data per day. To enable round the clock computing with as little down time as possible, the Institute opted for the Panasas PanFS parallel file system.

Sep 18, 2015, 12:21 PM by Michael Croft

NPR.org | After Chinese scientists announced in April that they had edited the genes in human embryos, many researchers said it shouldn't be done. Scientists in London say they want to do it for research only.

Sep 18, 2015, 09:00 AM by Michael Croft

Bio-IT World | Two weeks before Edico was ready to go public, Shawn Levy of HudsonAlpha was happily telling us of his expereince with Edico's DRAGEN card, a bio-IT processor that claims to massively accelerate secondary analysis algorithms while simultaneously improving accuracy. Levy calls it--in a word--amazing.

Sep 17, 2015, 17:32 PM by Michael Croft

MALVERN, PA - Sep 17, 2015 - CSM is pleased to announce that it will hold a Grand Opening and Ribbon-Cutting ceremony for its newly constructed facility at 300 Technology Drive in the Great Valley Corporate Center of Malvern, Pennsylvania on Thursday, October 15th from 1 p

Sep 16, 2015, 11:21 AM by Michael Croft

Washington Post | Researchers say they've identified a set of genetic variants that may here is evidence that these genes may facilitate lifespan extension by increasing cellular maintenance and repair.

Sep 15, 2015, 13:17 PM by Michael Croft

The New York Times | Dr. Thomas R. Insel announced that he is stepping down after 13 years as director of the National Institute of Mental Health to join Google Life Sciences.

Sep 15, 2015, 09:00 AM by Michael Croft

Bio-IT World Eric Dishman, an Intel Fellow and general manager of the Health and Life Sciences for the Data Center Group, shared his own precision medicine story at the inaugural Converged IT Summit* co-hosted by the BioTeam and Cambridge Healthtech Institute, setting the tone for a two-day look at trends from the trenches of IT and life sciences discovery.

Sep 14, 2015, 14:02 PM by Michael Croft

MINNEAPOLIS, MN, UNITED STATES - Sep 14, 2015 - DaVita Clinical Research® (DCR®), a specialty contract research organization with services spanning a broad spectrum of drug and device development, announced today its Biospecimen ResearchGrant Program (BioReG), a grant program to award clinical-trial-quality biospecimens and annotated de-identified data to academic medical centers involved in kidney research